Status:

RECRUITING

Rickettsia Clearance Study

Lead Sponsor:

Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

Collaborating Sponsors:

Mahidol Oxford Tropical Medicine Research Unit

Conditions:

Infectious Disease

Therapeutics

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Murine typhus is a disease caused by Rickettisa typhi, an obligate intracellular bacterium transmitted by rodent fleas. The disease has a worldwide distribution; however the true burden is unknown, re...

Eligibility Criteria

Inclusion

  • Age above or equal 18 years
  • Able to take oral medication
  • Rapid test positive for murine typhus or scrub typhus
  • Agrees to stay in hospital for at least 36 hours and to attend for scheduled follow up visits
  • Written informed consent to participate in the study
  • A negative urinary pregnancy test for all women of child-bearing age

Exclusion

  • Pregnancy or breast feeding
  • Previous allergic reaction to doxycycline or azithromycin
  • Received more than one dose of chloramphenicol, doxycycline, tetracycline, fluoroquinolones, rifampicin or azithromycin during this hospital admission or more than one dose of any of these drugs in the week before admission
  • Contraindication to doxycycline: severe hepatic impairment, known SLE
  • Contraindication to azithromycin: sever hepatic impairment
  • Severe typhus defined as the presence of one or more of the following:
  • Reduced level of consciousness
  • Clinical jaundice
  • Shock (BP systolic \<80 mmHg)
  • Unable to take oral medication
  • Radiological evidence of pneumonia
  • Clinical evidence for meningitis/encephalitis or the need of LP
  • Alternative diagnosis confirmed that explains the presenting symptoms
  • Any other syndrome which in the opinion of the admitting doctor constitutes severe typhus (reason must be stated)

Key Trial Info

Start Date :

November 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2026

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT05972772

Start Date

November 1 2024

End Date

August 31 2026

Last Update

December 27 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)

Vientiane, Vientaine, Laos, 0103

2

Vientiane Provincial Hospital

Vientiane Province, Vientiane Province, Laos

Rickettsia Clearance Study | DecenTrialz